Renal cell carcinoma: Allelic loss at chromosome 9 using the fluorescent multiplex-polymerase chain reaction technique

Human Pathology

Volumn 33, Issue 9, 2002, Pages 910-914

  Fukunaga, Koji ^a   Wada, Takashi ^a   Matsumoto, Hiroaki ^a   Yoshihiro, Satoru ^a   Matsuyama, Hideyasu ^a   Naito, Katsusuke ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chromosome 9; Loss of heterozygosity; Nuclear grade; Renal cell carcinoma; Tumor stage

Indexed keywords

DNA;

ADULT; AGED; ALLELE; ARTICLE; CANCER GRADING; CANCER STAGING; CHROMOSOME 9Q; CHROMOSOME MAP; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PERIPHERAL LYMPHOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0036742816     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.126877     Document Type: Article

References (34)

1. Wilhelm M, Bugert P, Kenck C, et al: Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: A breakpoint cluster between loci D3S1285 and D3S1603. Cancer Res 55:5383-5385, 1995
2. Gnarra JR, Tory K, Weng Y, et al: Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Gen 7:85-90, 1994
3. Kenck C, Wilhelm M, Bugert P, et al: Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas. J Pathol 179:157-161, 1996
4. Morita R, Ishikawa J, Tsutsumi M, et al: Allelotype of renal cell carcinoma. Cancer Res 51:820-823, 1991
5. Brooks JD, Bova GS, Marshall FF, et al: Tumor suppressor gene allelic loss in human renal cancers. J Urol 150:1278-1283, 1993
6. Foster K, Crossey PA, Cairns P, et al: Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer 69:230-234, 1994
7. Tsai YC, Nichols PW, Hiti AL, et al: Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res 50:44-47, 1990
8. Cairns P, Shaw ME, Knowles MA: Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene 8:1083-1085, 1993
9. Merlo A, Gabrielson E, Askin F, et al: Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 54:640-642, 1994
10. Gailani MR, Bale SJ, Leffell DJ, et al: Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 69:111-117, 1992
11. van der Riet P, Karp D, Farmer E, et al: Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele. Cancer Res 54:25-27, 1994
12. Maesawa C, Tamura G, Iwaya T, et al: Mutations in the human homologue of the Drosophila patched gene in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 21:276-279, 1998
13. Raffel C, Jenkins RB, Frederick L, et al: Sporadic medulloblastomas contain PTCH mutations. Cancer Res 57:842-845, 1997
14. Xie J, Johnson RL, Zhang X, et al: Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res 57:2369-2372, 1997
15. Louhelainen J, Lindstrom E, Hemminki K, et al: Dinucleotide repeat polymorphism within the tumor suppressor gene PTCH at 9q22. Clin Genet 54:239-241, 1998
16. Sambrook J, Fritschookstein EF, Maniatis T: Molecular Cloning: A Laboratory Manual (2nd ed). Woodbury, NY, Cold Spring Harbor Laboratory Press, 1989
17. Beahrs OH (ed): American Joint Committee on Cancer's Manual for Staging Cancer (4th ed). Philadelphia, PA, Lippincott, 1992
18. Japanese Urological Association. The Japanese Society of Pathology, Japan Radiological Society: General Rule for Clinical and Pathological Studies on Renal Cell Carcinoma (2nd ed). Tokyo, Japan, Kanahara, 1992
19. Cairns P, Tokino K, Eby Y, et al: Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res 55:224-227, 1995
20. Schullerus D, Herbers J, Chudek J, et al: Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas. J Pathol 183:151-155, 1997
21. Schraml P, Struckmann K, Bednar R, et al: CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: Evidence for a second tumor suppressor gene proximal to CDKN2A. Am J Pathol 158:593-601, 2001
22. Chino K, Esumi M, Ishida H, et al: Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma. J Urol 162:614-618, 1999
23. Junker K, Moravek P, Podhola M, et al: Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridization: Correlation with clinical and histological data. Int J Oncol 17:903-908, 2000
24. Cairns P, Polascik TJ, Eby Y, et al: Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 11:210-212, 1995
25. Fountain JW, Karayiorgou M, Ernstoff MS, et al: Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Nat Acad Sci USA 89:10557-10561, 1992
26. Schraml P, Muller D, Bednar R, et al: Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma. J Pathol 190:457-461, 2000
27. Hahn H, Wicking C, Zaphiropoulous PG, et al: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841-851, 1996
28. Johnson RL, Rothman AL, Xie J, et al: Human homolog of patched, a candidate gene for the basal cell nervus syndrome. Science 272:1668-1671, 1996
29. Sidransky D: Is human patched the gatekeeper of common skin cancers? [letter; comment]. Nat Genet 14:7-8, 1996
30. Unden AB, Zaphiropoulos PG, Bruce K, et al: Human patched (PTCH) mRNA is overexpressed consistently in tumor cells of both familial and sporadic basal cell carcinoma. Cancer Res 57: 2336-2340, 1997
31. Vorechovsky I, Unden AB, Sandstedt B, et al: Trichoepitheliomas contain somatic mutations in the overexpressed PTCH gene: Support for a gatekeeper mechanism in skin tumorigenesis. Cancer Res 57:4677-4681, 1997
32. Pietsch T, Waha A, Koch A, et al: Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 57:2085-2088, 1997
33. Wolter M, Reifenberger J, Sommer C, et al: Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 57:2581-2585, 1997
34. Vorechovsky I, Tingby O, Hartman M, et al: Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours. Oncogene 15:361-366, 1997